Company Profiles

driven by the PitchBook Platform

NeuroGenetic Pharmaceuticals

Description

Developer of drugs for the prevention of neurodegenerative conditions designed to treat Alzheimer's disease. The company's patented technology of Gamma-Secretase Modulators (GSMs) is based on an innovative modulation of a key enzyme in the amyloid pathway, called γ-secretase, enabling patients to start their treatment before the onset of dementia.

2009

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$5M

Latest Deal Amount

$4.4M

Total Amount Raised

Description

Developer of drugs for the prevention of neurodegenerative conditions designed to treat Alzheimer's disease. The company's patented technology of Gamma-Secretase Modulators (GSMs) is based on an innovative modulation of a key enzyme in the amyloid pathway, called γ-secretase, enabling patients to start their treatment before the onset of dementia.

Website:

www.neurogeneticpharmaceuticals.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

445 Marine View Avenue Suite 101 Del Mar, CA 92014United States +1 (858) 461-4480
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore NeuroGenetic Pharmaceuticals's full profile, request a free trial.

    NeuroGenetic Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    NeuroGenetic Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    NeuroGenetic Pharmaceuticals Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AbbVie VenturesCorporate Venture CapitalMinority000 0000000 0000
    National Institute of Aging (NIA)Other000 0000000 0000
    National Institutes of HealthGovernment000 0000000 0000
    AbbVie Ventures Corporate Venture Capital
    National Institute of Aging (NIA) Other
    National Institutes of Health Government

    NeuroGenetic Pharmaceuticals Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    William Comer Ph.DCo-Founder, Chairman & Chief Executive Officer
    Rudolph Tanzi Ph.DCo-Founder
    Steven WagnerCo-Founder
    Janet McCleanManager, Finance
    Maria Kounnas Ph.DSenior Vice President, Research
    William Comer Ph.D Co-Founder, Chairman & Chief Executive Officer
    Rudolph Tanzi Ph.D Co-Founder
    Steven Wagner Co-Founder
    Janet McClean Manager, Finance
    Maria Kounnas Ph.D Senior Vice President, Research

    NeuroGenetic Pharmaceuticals Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Barry QuartSelfBoard Member000 0000
    Thomas ReedSelfBoard Member000 0000
    William Comer Ph.DNeuroGenetic PharmaceuticalsCo-Founder, Chairman & Chief Executive Officer000 0000
    Barry Quart Board Member Self
    Thomas Reed Board Member Self
    William Comer Ph.D Co-Founder, Chairman & Chief Executive Officer NeuroGenetic Pharmaceuticals
    Request full access to PitchBook